tert-butyl 1,8-dioxa-5-azaspiro[2.6]nonane-5-carboxylate

Catalog No. :
ACNQLG510
CAS No. :
1063733-66-3
Molecular Formula :
C11H19NO4
Molecular Weight :
229.28

IUPAC Name:tert-butyl 1,5-dioxa-8-azaspiro[2.6]nonane-8-carboxylate

tert-butyl 1,8-dioxa-5-azaspiro[2.6]nonane-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$100.00Login to see priceIn stockInquiry
250mg97%$135.00Login to see priceIn stockInquiry
500mg97%$222.00Login to see priceIn stockInquiry
1g97%$333.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl 1,8-dioxa-5-azaspiro[2.6]nonane-5-carboxylate
IUPAC Nametert-butyl 1,5-dioxa-8-azaspiro[2.6]nonane-8-carboxylate
MDL No.0
Molecular FormulaC11H19NO4
Molecular Weight229.28
SMILESCC(C)(C)OC(=O)N1CCOCC2(CO2)C1
InChI KeyFRFINYDYCUOIEK-UHFFFAOYSA-N
Synonym8-Boc-1,5-dioxa-8-azaspiro[2.6]nonane | EN300-6496926 | TERT-BUTYL 1,5-DIOXA-8-AZASPIRO[2.6]NONANE-8-CARBOXYLATE | AT33320 | PS-20905 | tert-Butyl 1,5-dioxa-8-azaspiro[2.6]nonane-8-carboxylate, AldrichCPR | SY324346 | 1063733-66-3 | Z1505698506 | SCHEMBL1
CAS No.1063733-66-3
PubChem CID57732105

Synthetic Route by SureRoute

1. ACNQLG510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCNMB168 route compound structure diagram
    ACCNMB168748805-97-2 In Stock
  2. Plus
  3. ACNXUH296 route compound structure diagram
    ACNXUH2961774-47-6 In Stock
  4. Then
  5. ACNQLG510 route product structure diagram
    ACNQLG5101063733-66-3 In Stock
Inquiry

2. ACNQLG510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZUXV039 route compound structure diagram
    ACZUXV039748805-96-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNQLG510 route product structure diagram
    ACNQLG5101063733-66-3 In Stock
Inquiry

Comments (0)